Apogee Therapeutics Inc banner
A

Apogee Therapeutics Inc
NASDAQ:APGE

Watchlist Manager
Apogee Therapeutics Inc
NASDAQ:APGE
Watchlist
Price: 77.82 USD -0.77% Market Closed
Market Cap: $5.4B

Wall Street
Price Targets

APGE Price Targets Summary
Apogee Therapeutics Inc

Wall Street analysts forecast APGE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for APGE is 118.86 USD with a low forecast of 82.82 USD and a high forecast of 168 USD.

Lowest
Price Target
82.82 USD
6% Upside
Average
Price Target
118.86 USD
53% Upside
Highest
Price Target
168 USD
116% Upside
Apogee Therapeutics Inc Competitors:
Price Targets
ARDX
Ardelyx Inc
196% Upside
CIGI
Colliers International Group Inc
26% Upside
PRQR
ProQR Therapeutics NV
542% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-17%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-17%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is APGE's stock price target?
Price Target
118.86 USD

According to Wall Street analysts, the average 1-year price target for APGE is 118.86 USD with a low forecast of 82.82 USD and a high forecast of 168 USD.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett